In conclusion, our data suggest that CP2c expression correlates with HCC initiation and progression, and that combined detection of high nuclear YY1 and high CP2c expression shows a poor outcome in the HCC patients. This evidence concerns the gene YY1 and hepatocellular carcinoma.